Affordable Access

deepdyve-link
Publisher Website

Defining response profiles after alemtuzumab: Rare paradoxical disease exacerbation.

Authors
  • Wiendl, Heinz1
  • Calabresi, Peter A2
  • Meuth, Sven G2
  • 1 From the Department of Neurology and Institute of Translational Neurology (H.W., S.G.M.), Westfälische Wilhelms-Universität Münster, Germany; and Departments of Neurology and Neuroscience (P.A.C.), Johns Hopkins University, Baltimore, MD. [email protected] , (Germany)
  • 2 From the Department of Neurology and Institute of Translational Neurology (H.W., S.G.M.), Westfälische Wilhelms-Universität Münster, Germany; and Departments of Neurology and Neuroscience (P.A.C.), Johns Hopkins University, Baltimore, MD. , (Germany)
Type
Published Article
Journal
Neurology
Publisher
Ovid Technologies (Wolters Kluwer) - American Academy of Neurology
Publication Date
Feb 13, 2018
Volume
90
Issue
7
Pages
309–311
Identifiers
DOI: 10.1212/WNL.0000000000004969
PMID: 29352097
Source
Medline
Language
English
License
Unknown
Report this publication

Statistics

Seen <100 times